Paul Toren

11PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursTumour immunologyOther creative arts and writing not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Mar 23, 2024
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.

Karine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi

|Oct 03, 2023
Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.

Josée Savard, Hanane Moussa, Jean-François Pelletier

|Aug 21, 2023
The sex gap in bladder cancer survival - a missing link in bladder cancer care?

Paul Toren, Anna Wilkins, Keval Patel

|Jan 25, 2022
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype.

Clovis Boibessot, Oscar Molina, Gabriel Lachance

|Aug 12, 2021
Reply by Authors.

Samuel Tremblay, Lily Summers-Trasiewicz, Frédéric Pouliot

Pageof 2

Frequent Collaborators

2 joint publications

Vincent Fradet

2 joint publications

Samuel Tremblay

2 joint publications

Juanita M Crook

2 joint publications

Laurence Klotz